Zogenix Announces Clinical Study Results For Sumatriptan DosePro?, A Novel Migraine Treatment
Jun 30th 2008Drug InformationHeadache / Migraine
Zogenix, Inc. (”Zogenix”), a private, specialty pharmaceutical company, announced that it will present successful results from two clinical studies of sumatriptan DosePro, a product in development for treatment of acute migraine and cluster headache, at the 50th Annual American Headache Society Meeting in Boston, Massachusetts.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
